164 related articles for article (PubMed ID: 36445620)
1. Recurrence of hepatocellular carcinoma after radiofrequency ablation in a poor-risk patient with chronic renal failure and other complications successfully treated with stereotactic body radiotherapy.
Saito T; Takakusagi S; Takagi H; Yokoyama Y; Kizawa K; Marubashi K; Kosone T; Kiyohara H; Shibuya K; Uraoka T
Clin J Gastroenterol; 2023 Apr; 16(2):216-223. PubMed ID: 36445620
[TBL] [Abstract][Full Text] [Related]
2. Retrospective analysis of stereotactic body radiation therapy efficacy over radiofrequency ablation for hepatocellular carcinoma.
Kim N; Kim HJ; Won JY; Kim DY; Han KH; Jung I; Seong J
Radiother Oncol; 2019 Feb; 131():81-87. PubMed ID: 30773192
[TBL] [Abstract][Full Text] [Related]
3. Stereotactic body radiation therapy vs. radiofrequency ablation in Asian patients with hepatocellular carcinoma.
Kim N; Cheng J; Jung I; Liang J; Shih YL; Huang WY; Kimura T; Lee VHF; Zeng ZC; Zhenggan R; Kay CS; Heo SJ; Won JY; Seong J
J Hepatol; 2020 Jul; 73(1):121-129. PubMed ID: 32165253
[TBL] [Abstract][Full Text] [Related]
4. Stereotactic body radiotherapy versus radiofrequency ablation as initial treatment of small hepatocellular carcinoma.
Shin HS; Hwan Lee S; Jun BG; Kim HS; Kang SH; Park JY; Choi SI; Cheon GJ; Kim YD; Yoo JJ; Kim SG; Kim YS; Jeong SW; Jang JY; Suk KT; Kim DJ; Jo IY; Won YK
Eur J Gastroenterol Hepatol; 2022 Nov; 34(11):1187-1194. PubMed ID: 36170689
[TBL] [Abstract][Full Text] [Related]
5. Comparison of clinical outcome between stereotactic body radiotherapy and radiofrequency ablation for unresectable hepatocellular carcinoma.
Ji R; Ng KK; Chen W; Yang W; Zhu H; Cheung TT; Chiang CL; Wong TCL; Kong FM; Wu G; Lo CM
Medicine (Baltimore); 2022 Jan; 101(4):e28545. PubMed ID: 35089192
[TBL] [Abstract][Full Text] [Related]
6. Stereotactic body radiotherapy vs radiofrequency ablation for the treatment of hepatocellular carcinoma: a meta-analysis.
Facciorusso A; Chierici A; Cincione I; Sacco R; Ramai D; Mohan BP; Chandan S; Ofosu A; Cotsoglou C
Expert Rev Anticancer Ther; 2021 Jun; 21(6):681-688. PubMed ID: 33590783
[No Abstract] [Full Text] [Related]
7. Radiofrequency ablation and stereotactic body radiotherapy for hepatocellular carcinoma: should they clash or reconcile?
Rim CH; Lee HY; Kim JS; Kim H
Int J Radiat Biol; 2021; 97(2):111-119. PubMed ID: 33253598
[TBL] [Abstract][Full Text] [Related]
8. Radiofrequency ablation versus stereotactic body radiation therapy for small (≤ 3 cm) hepatocellular carcinoma: A retrospective comparison analysis.
Jeong Y; Lee KJ; Lee SJ; Shin YM; Kim MJ; Lim YS; Lee HC; Jung J; Park JH; Kim JH; Kim SY; Yoon SM
J Gastroenterol Hepatol; 2021 Jul; 36(7):1962-1970. PubMed ID: 33594690
[TBL] [Abstract][Full Text] [Related]
9. Hepatitis C virus relapse after successful treatment with direct-acting antivirals, followed by sarcomatous changes in hepatocellular carcinoma: a case report.
Kurokawa K; Ohki T; Kato J; Fukumura Y; Imai M; Shibata C; Arai J; Kondo M; Takagi K; Kojima K; Seki M; Mori M; Toda N; Tagawa K
J Med Case Rep; 2020 May; 14(1):62. PubMed ID: 32456712
[TBL] [Abstract][Full Text] [Related]
10. Stereotactic body radiation therapy versus radiofrequency ablation in hepatocellular carcinoma: an up-date meta-analysis.
Yang D; Lin K; Wang Y; Xie X; Xie X; Zhuang B
Abdom Radiol (NY); 2023 Jan; 48(1):399-410. PubMed ID: 36287228
[TBL] [Abstract][Full Text] [Related]
11. Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
Wang L; Ke Q; Huang Q; Shao L; Chen J; Wu J
Int J Hyperthermia; 2020; 37(1):1313-1321. PubMed ID: 33243024
[TBL] [Abstract][Full Text] [Related]
12. Radiofrequency ablation versus stereotactic body radiation therapy for hepatocellular carcinoma: a meta-regression.
Malik A; Jairam MP; Chow R; Mirshahvalad SA; Veit-Haibach P; Simone CB
Future Oncol; 2023 Feb; 19(4):279-287. PubMed ID: 36916490
[No Abstract] [Full Text] [Related]
13. Radiofrequency ablation versus stereotactic body radiotherapy for small hepatocellular carcinoma: a Markov model-based analysis.
Seo YS; Kim MS; Yoo HJ; Jang WI; Paik EK; Han CJ; Lee BH
Cancer Med; 2016 Nov; 5(11):3094-3101. PubMed ID: 27709795
[TBL] [Abstract][Full Text] [Related]
14. Radiofrequency ablation versus stereotactic body radiotherapy for hepatocellular carcinoma: a meta-analysis.
Zhang H; Chang N; Han T; Ma S; Qu G; Liu H; Sun C; Cheng C; Zhou Q; Sun Y
Future Oncol; 2021 Oct; 17(30):4027-4040. PubMed ID: 34278818
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic Outcome of Stereotactic Body Radiotherapy for Small Hepatocellular Carcinoma Lesions - A Systematic Review and Network Meta-analysis.
Li LQ; Su TS; Wu QY; Lin ZT; Liang SX
Clin Oncol (R Coll Radiol); 2023 Oct; 35(10):652-664. PubMed ID: 37541936
[TBL] [Abstract][Full Text] [Related]
16. Outcomes After Stereotactic Body Radiotherapy or Radiofrequency Ablation for Hepatocellular Carcinoma.
Wahl DR; Stenmark MH; Tao Y; Pollom EL; Caoili EM; Lawrence TS; Schipper MJ; Feng M
J Clin Oncol; 2016 Feb; 34(5):452-9. PubMed ID: 26628466
[TBL] [Abstract][Full Text] [Related]
17. Local control by salvage stereotactic body radiotherapy for recurrent/residual hepatocellular carcinoma after other local therapies.
Kibe Y; Takeda A; Tsurugai Y; Eriguchi T
Acta Oncol; 2020 Aug; 59(8):888-894. PubMed ID: 32216593
[No Abstract] [Full Text] [Related]
18. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
[TBL] [Abstract][Full Text] [Related]
19. Radiotherapy for Hepatocellular Carcinoma Results in Comparable Survival to Radiofrequency Ablation: A Propensity Score Analysis.
Hara K; Takeda A; Tsurugai Y; Saigusa Y; Sanuki N; Eriguchi T; Maeda S; Tanaka K; Numata K
Hepatology; 2019 Jun; 69(6):2533-2545. PubMed ID: 30805950
[TBL] [Abstract][Full Text] [Related]
20. Effectiveness and cost of radiofrequency ablation and stereotactic body radiotherapy for treatment of early-stage hepatocellular carcinoma: An analysis of SEER-medicare.
Parikh ND; Marshall VD; Green M; Lawrence TS; Razumilava N; Owen D; Singal AG; Feng M
J Med Imaging Radiat Oncol; 2018 Oct; 62(5):673-681. PubMed ID: 29877615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
